Cocrystal Pharma Announces $40 Million Bought Deal Offering of Common Stock
04 mai 2021 18h41 HE
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., May 04, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
Aeterna Zentaris Increases Previously Announced Bought Deal Offering of Common Shares to $29.7 Million
16 févr. 2021 22h00 HE
|
Aeterna Zentaris Inc
CHARLESTON, S.C., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and...
Cancer Genetics, Inc. Announces $2.0 Million Bought Deal Offering
28 oct. 2020 17h54 HE
|
Cancer Genetics, Inc.
Rutherford, N.J., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX) (“Cancer Genetics”), a leader in in drug discovery and preclinical oncology and immuno-oncology services,...